Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule

Alexander S. Hahn, Ronald Charles Desrosiers

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The ephrin receptor tyrosine kinase A2 (EphA2) is an entry receptor for Kaposi's sarcoma-associated herpesvirus (KSHV) that is engaged by the virus through its gH/gL glycoprotein complex. We describe here that natural ephrin ligands inhibit the gH/gLEphA2 interaction. The effects of point mutations within EphA2 demonstrated that KSHV gH/gL interacts with EphA2 through a restricted set of the same residues that mediate binding of A-type ephrins. Two previously described inhibitors of the EphA2 interaction with ephrin A5 also inhibited binding of KSHV gH/gL to EphA2. The more potent of the two compounds inhibited KSHV infection of blood vessel and lymphatic endothelial cells in the micromolar concentration range. Our results demonstrate that interaction of KSHV with EphA2 occurs in a fashion similar to that of the natural ephrin ligands. Our data further indicate a new avenue for drug development against KSHV.

Original languageEnglish (US)
Pages (from-to)8724-8734
Number of pages11
JournalJournal of Virology
Volume88
Issue number16
DOIs
StatePublished - 2014

Fingerprint

EphA2 Receptor
Human herpesvirus 8
Ephrins
Human Herpesvirus 8
receptors
Ephrin-A5
receptor protein-tyrosine kinase
Eph Family Receptors
Ligands
Herpesviridae Infections
new drugs
point mutation
Point Mutation
varespladib methyl
blood vessels
endothelial cells
Blood Vessels
tyrosine
glycoproteins
Glycoproteins

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

@article{7bd382b03db449e9982b80796d2415a3,
title = "Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule",
abstract = "The ephrin receptor tyrosine kinase A2 (EphA2) is an entry receptor for Kaposi's sarcoma-associated herpesvirus (KSHV) that is engaged by the virus through its gH/gL glycoprotein complex. We describe here that natural ephrin ligands inhibit the gH/gLEphA2 interaction. The effects of point mutations within EphA2 demonstrated that KSHV gH/gL interacts with EphA2 through a restricted set of the same residues that mediate binding of A-type ephrins. Two previously described inhibitors of the EphA2 interaction with ephrin A5 also inhibited binding of KSHV gH/gL to EphA2. The more potent of the two compounds inhibited KSHV infection of blood vessel and lymphatic endothelial cells in the micromolar concentration range. Our results demonstrate that interaction of KSHV with EphA2 occurs in a fashion similar to that of the natural ephrin ligands. Our data further indicate a new avenue for drug development against KSHV.",
author = "Hahn, {Alexander S.} and Desrosiers, {Ronald Charles}",
year = "2014",
doi = "10.1128/JVI.01392-14",
language = "English (US)",
volume = "88",
pages = "8724--8734",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "16",

}

TY - JOUR

T1 - Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule

AU - Hahn, Alexander S.

AU - Desrosiers, Ronald Charles

PY - 2014

Y1 - 2014

N2 - The ephrin receptor tyrosine kinase A2 (EphA2) is an entry receptor for Kaposi's sarcoma-associated herpesvirus (KSHV) that is engaged by the virus through its gH/gL glycoprotein complex. We describe here that natural ephrin ligands inhibit the gH/gLEphA2 interaction. The effects of point mutations within EphA2 demonstrated that KSHV gH/gL interacts with EphA2 through a restricted set of the same residues that mediate binding of A-type ephrins. Two previously described inhibitors of the EphA2 interaction with ephrin A5 also inhibited binding of KSHV gH/gL to EphA2. The more potent of the two compounds inhibited KSHV infection of blood vessel and lymphatic endothelial cells in the micromolar concentration range. Our results demonstrate that interaction of KSHV with EphA2 occurs in a fashion similar to that of the natural ephrin ligands. Our data further indicate a new avenue for drug development against KSHV.

AB - The ephrin receptor tyrosine kinase A2 (EphA2) is an entry receptor for Kaposi's sarcoma-associated herpesvirus (KSHV) that is engaged by the virus through its gH/gL glycoprotein complex. We describe here that natural ephrin ligands inhibit the gH/gLEphA2 interaction. The effects of point mutations within EphA2 demonstrated that KSHV gH/gL interacts with EphA2 through a restricted set of the same residues that mediate binding of A-type ephrins. Two previously described inhibitors of the EphA2 interaction with ephrin A5 also inhibited binding of KSHV gH/gL to EphA2. The more potent of the two compounds inhibited KSHV infection of blood vessel and lymphatic endothelial cells in the micromolar concentration range. Our results demonstrate that interaction of KSHV with EphA2 occurs in a fashion similar to that of the natural ephrin ligands. Our data further indicate a new avenue for drug development against KSHV.

UR - http://www.scopus.com/inward/record.url?scp=84904909324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904909324&partnerID=8YFLogxK

U2 - 10.1128/JVI.01392-14

DO - 10.1128/JVI.01392-14

M3 - Article

C2 - 24899181

AN - SCOPUS:84904909324

VL - 88

SP - 8724

EP - 8734

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 16

ER -